KR102436816B1 - Cosmetic composition - Google Patents

Cosmetic composition Download PDF

Info

Publication number
KR102436816B1
KR102436816B1 KR1020220002831A KR20220002831A KR102436816B1 KR 102436816 B1 KR102436816 B1 KR 102436816B1 KR 1020220002831 A KR1020220002831 A KR 1020220002831A KR 20220002831 A KR20220002831 A KR 20220002831A KR 102436816 B1 KR102436816 B1 KR 102436816B1
Authority
KR
South Korea
Prior art keywords
weight
parts
extract
graviola
effect
Prior art date
Application number
KR1020220002831A
Other languages
Korean (ko)
Other versions
KR20220027092A (en
Inventor
이호규
Original Assignee
이호규
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 이호규 filed Critical 이호규
Priority to KR1020220002831A priority Critical patent/KR102436816B1/en
Publication of KR20220027092A publication Critical patent/KR20220027092A/en
Application granted granted Critical
Publication of KR102436816B1 publication Critical patent/KR102436816B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/522Antioxidants; Radical scavengers

Abstract

본 발명은 그라비올라 한방 추출물을 포함하는 화장료 조성물에 관한 것이다. 보다 상세하게는, 본 발명은 항산화효과, 미백효과, 주름개선효과 및 항염증 효과가 있는 화장료 조성물에 관한 것이다.
본 발명에 따른 항산화효과, 미백효과, 주름개선효과 및 항염증 효과가 있는 화장료 조성물은 인체 친화적 천연 화장품으로서, 항균력이 있는 그라비올라 수를 포함하고 있어서 인체 피부에 무해하고 민감성 피부를 가진 사람에게도 쉽게 사용할 수 있다. 또한, 모발 성장 촉진에 효과적으로 작용하고, 두피 모근을 자극해 탈모예방에도 도움을 줄 뿐만 아니라 모발을 효과적으로 생장시킬 수 있는 장점이 있다.
The present invention relates to a cosmetic composition comprising a graviola herbal extract. More particularly, the present invention relates to a cosmetic composition having an antioxidant effect, a whitening effect, an anti-wrinkle effect, and an anti-inflammatory effect.
The cosmetic composition having antioxidant effect, whitening effect, wrinkle improvement effect and anti-inflammatory effect according to the present invention is a human-friendly natural cosmetic, and contains graviola water with antibacterial activity, so it is harmless to human skin and easily accessible even to people with sensitive skin. Can be used. In addition, it effectively acts to promote hair growth, stimulates the scalp hair root, helps prevent hair loss, and has the advantage of effectively growing hair.

Figure 112022002479235-pat00001
Figure 112022002479235-pat00001

Description

그라비올라 한방 추출물을 포함하는 화장료 조성물{Cosmetic composition}Cosmetic composition comprising graviola herbal extract {Cosmetic composition}

본 발명은 그라비올라 한방 추출물을 포함하는 화장료 조성물에 관한 것으로, 항산화효과, 미백효과, 주름개선효과 및 항염증 효과가 있는 화장료 조성물에 관한 것이다. The present invention relates to a cosmetic composition comprising a graviola herbal extract, and to a cosmetic composition having an antioxidant effect, a whitening effect, an anti-wrinkle effect, and an anti-inflammatory effect.

머리카락은 하루에 80~100개 정도가 정상적으로 빠지며 빠진 자리에는 새로운 모발이 형성되게 된다. 탈모는 머리카락이 새로 형성되는 숫자보다 빠지는 숫자가 더 많은 상태를 말하는 것으로, 탈모의 원인은 개인에 따라 다르지만, 유전적인 요인, 두피 및 건강 관리 상태 및 스트레스 등을 주요 원인으로 들 수 있다. 혈액순환이 잘 되면 모근에 영양분과 산소가 원활하게 공급되어 모발이 건강하게 자라지만, 고지방식이나 흡연 등으로 혈액순환이 원활하지 않으면 탈모가 촉진된다. 현대 사회에서는 탈모를 고민하는 사람들의 수가 점점 늘어나고 있으며 그 연령층이 점점 낮아지는 실정이다. About 80 to 100 hairs fall out a day normally, and new hairs are formed in the places where they fall out. Hair loss refers to a condition in which the number of hairs falling out is greater than the number of newly formed hairs. The causes of hair loss vary depending on the individual, but genetic factors, scalp and health care conditions, and stress are the main causes. When blood circulation is good, nutrients and oxygen are smoothly supplied to the hair roots, and hair grows healthy. However, if blood circulation is not smooth due to high fat diet or smoking, hair loss is promoted. In modern society, the number of people suffering from hair loss is increasing and the age group is getting lower.

탈모증을 치료하기 위한 종래의 발모 촉진용 약물 중 현재까지 미국 식품의약국(FDA)으로부터 탈모치료제로서 효능을 승인받은 제품으로는 경구용 피나스테라이드(Finasteride, Merk, 미국)와 외용제 미녹시딜(Minoxidil, Upjohn, 미국)의 두 가지가 알려져 있다. 미녹시딜은 모세혈관 확장 기능이 있어 두피에 바름으로써 탈모 방지 효과를 나타내지만, 지속적으로 두피에 발라야 하며, 일정 시간 약제가 두피에 머무르도록 해야만 효과가 나타나고, 가려움증이나 자극 등의 부작용이 나타나고 있다. 피나스테라이드는 탈모를 유발하는 남성호르몬인 DHT(5α-dihydrotestosterone) 생성 억제 기능이 있고, 장기 복용시 탈모 억제 효과가 나타나지만, 복용을 중단하면 원상태로 되돌아가는 문제점이 있다. 또한, 부작용으로서 성욕감퇴 및 발기부전 등의 성기능 감퇴 등이 있으며, 여성은 기형아 출산의 위험이 있어서 복용해서는 안 되는 것으로 알려져 있다. 즉, 종래 사용되던 탈모 방지제는 화학물질을 사용한 것으로서, 일시적인 혈류 유통에 의해 모세혈관을 확장하여 모근에 자극을 주는 것이므로 그 효과가 일시적일 뿐만 아니라 과다 분비된 피지에 의한 탈모에만 효과가 한정된다는 문제점도 있다. Among the conventional drugs for promoting hair growth for the treatment of alopecia, the products that have been approved for the efficacy as a hair loss treatment by the US Food and Drug Administration (FDA) so far include oral finasteride (Finasteride, Merk, USA) and topical minoxidil (Minoxidil, Upjohn, United States), two are known. Minoxidil has a capillary dilatation function, so it has an effect of preventing hair loss by applying it to the scalp, but it has to be applied to the scalp continuously, and the effect is shown only when the drug stays on the scalp for a certain period of time, and side effects such as itching and irritation are appearing. Finasteride has a function of inhibiting the production of DHT (5α-dihydrotestosterone), a male hormone that causes hair loss, and has an effect of inhibiting hair loss when taken for a long time, but there is a problem that it returns to its original state when taking it is stopped. In addition, as side effects, there are decreased sexual function such as decreased libido and erectile dysfunction, and it is known that women should not take it because there is a risk of giving birth to a deformed child. That is, the conventionally used anti-hair loss agent uses a chemical substance, and because it stimulates the hair root by expanding capillaries by temporary blood flow circulation, the effect is not only temporary, but the effect is limited only to hair loss due to excessively secreted sebum. there is also

최근 연구 보고에 의하면 화학적으로 유도된 산화적 스트레스를 두피에 가할 경우, 모발의 주기가 유의적으로 단축되고, 피지의 산화에서 유발되는 탈모가 발생한다고 알려져 있다. 또한, 다양한 항산화 물질들이 탈모의 예방 및 발모 촉진에 효과가 있음이 알려지고 있다. According to a recent study report, it is known that when chemically induced oxidative stress is applied to the scalp, the hair cycle is significantly shortened and hair loss induced by the oxidation of sebum occurs. In addition, it is known that various antioxidants are effective in preventing hair loss and promoting hair growth.

생약 성분의 추출물을 이용하여 두피에 바르거나 복용하여 탈모를 방지하고 발모를 촉진하려는 시도 또한 많이 알려져 있다. 대한민국 등록특허공보 제 10-780180호 (숙지황, 산수유, 택사, 산약, 복령 및 목단피를 이용하는 경우), 대한민국 등록특허공보 제 10-1103651호(측백엽, 고삼, 단삼, 박하, 한련초, 후박의 6가지 한방 생약제제의 추출물을 이용하는 경우) 및 대한민국 등록특허공보 제 10-1155502호(상백피, 감초, 의이인, 갈조, 인삼, 고삼 및 은행잎의 추출물을 이용하는 경우) 등 상기의 문제점을 해결하기 위한 많은 연구가 진행되고 있으나, 탈모를 방지하고 두피를 개선하기 위한 다양한 치료제들이 제시되었으나 현재까지 상기의 문제점을 근본적으로 해결하는데 있어서는 적절하지 못한 상태이다.Attempts to prevent hair loss and promote hair growth by applying or taking herbal extracts to the scalp are also well known. Republic of Korea Patent Publication No. 10-780180 (when using sukjihwang, cornflower oil, texas, sanyak, bokryeong and mulberry), Korean Patent Publication No. 10-1103651 (6 kinds of arborvitae, ginseng, dansam, peppermint, hanryeoncho, and sagebrush) Many studies have been conducted to solve the above problems, such as when extracts of herbal herbal preparations are used) and Republic of Korea Patent Publication No. 10-1155502 (in the case of using extracts of sangbaekpi, licorice, uiin, brown algae, ginseng, ginseng and ginkgo leaves) Although progress has been made, various therapeutic agents for preventing hair loss and improving the scalp have been proposed, but to date, they are not suitable for fundamentally solving the above problems.

이에 본 발명자들은 상기 종래기술의 한계를 극복하는 신규한 탈모 방지 조성물을 개발하고자 노력한 결과, 항산화물질인 파이토케미칼(phytochemicals) 성분 및 아세토제닌(acetogenin) 성분을 함유하는 그라비올라 추출물의 항균 활성, 피부세포의 증식 향상 효과를 확인하고 그라비올라 추출물, 한약 소재 추출물 및 코퍼펩타이드를 복합 처방한 헤어 샴푸의 우수한 탈모 방지 및 두피 개선 효과를 확인함으로써, 본 발명을 완성하였다. Accordingly, the present inventors have tried to develop a novel anti-hair loss composition that overcomes the limitations of the prior art. As a result, the antibacterial activity of graviola extract containing antioxidants phytochemicals and acetogenin, skin The present invention was completed by confirming the effect of improving the proliferation of cells and confirming the excellent effect of preventing hair loss and improving the scalp of a hair shampoo in which graviola extract, herbal extract and copper peptide were combined.

대한민국 등록특허공보 제 10-780180호Republic of Korea Patent Publication No. 10-780180 대한민국 등록특허공보 제 10-1103651호Republic of Korea Patent Publication No. 10-1103651 대한민국 등록특허공보 제 10-1155502호Republic of Korea Patent Publication No. 10-1155502

Blois MS. 1958, Nature, 26, 1199-1120.Blois MS. 1958, Nature, 26, 1199-1120. Roberta R 외, 1999, Free radical biology & Medicine, 26(9/10), 1231-1237.Roberta R et al., 1999, Free radical biology & Medicine, 26(9/10), 1231-1237. Stirpe F 외, 1969, J. Biol. Chem., 244(14), 3855-3863.Stirpe F et al., 1969, J. Biol. Chem., 244(14), 3855-3863. Marklund S 외, 1974, Eur J Biochem., 47(3), 469-474.Marklund S et al., 1974, Eur J Biochem., 47(3), 469-474. Carmichael J 외, 1987, Cancer Res., 47(4), 936-942.Carmichael J et al., 1987, Cancer Res., 47(4), 936-942. Yagi A 외, 1986, 3981, 517-519.Yagi A et al., 1986, 3981, 517-519. Hosoi J 외, 1985, Cancer Res., 45(4), 1474-1478.Hosoi J et al., 1985, Cancer Res., 45(4), 1474-1478.

이와 같이, 본 발명은 그라비올라 추출물을 기반으로 하고 한방 추출물 및 카퍼트리펩타이드를 추가로 포함하는 탈모 방지 및 두피 개선용 모발 화장료 조성물 및 이의 제조방법을 제공하는 것을 목적으로 한다. As such, an object of the present invention is to provide a hair cosmetic composition for preventing hair loss and improving the scalp, which is based on the graviola extract and further comprising an herbal extract and copper tripeptide, and a method for preparing the same.

또한, 항산화효과, 미백효과, 주름개선효과 및 항염증 효과가 있다.In addition, it has an antioxidant effect, a whitening effect, an anti-wrinkle effect, and an anti-inflammatory effect.

상기 본 발명의 목적을 달성하기 위해, 본 발명은 일 구체예에서, 다음의 단계를 포함하는 항산화효과, 미백효과, 주름개선효과 및 항염증 효과가 있는 화장료 조성물의 제조방법: 1) 정제수, 카보머 및 디소듐이디티에이를 90℃까지 가온하여 용해한 후 여과하는 단계; 2) 시크릭애씨드, 솔잣나무열매추출물, 글리세린, 디메치콘, 소듐라우릴설페이트 및 코카마이도프로필베타인을 70℃까지 가온하여 용해한 후 상기 1) 단계의 여과물과 혼합교반하는 단계; 3) 코카마이드디이에이, 아이오도프로피닐부틸카바메이트 및 글라이콜디스테아레이트를 70℃까지 가온하여 용해한 후 여과하여 상기 2) 단계의 생성물과 혼합교반하여 60℃까지 냉각하는 단계; 4) 세트리모늄클로라이드, 향료, 트리에탄올아민, 소듐클로라이드, 하이드롤라이즈케라틴, 하수오추출물, 홍삼추출물, 백지추출물, 한련초추출물, 당귀추출물, 석류추출물, 대황추출물, 카퍼트리펩타이드, 그라비올라 에탄올 추출물, 소듐라우레스에테르설페이트 및 그라비올라 열수 추출물을 상기 3) 단계의 생성물과 혼합 교반하여 60℃까지 냉각하고 여과하는 단계:을 제공한다. 상기 구체예에서, 정제수 13 내지 17 중량부, 카보너 0.1 내지 0.3 중량부, 디소듐이디티에이 0.05 내지 0.1 중량부, 시크릭애씨드 0.1 내지 0.3 중량부, 솔잣나무열매추출물 0.1 내지 0.3 중량부, 글리세린 1.5 내지 2.0 중량부, 디메치콘 1.5 내지 2.5 중량부, 소듐라우릴설페이트 8 내지 12 중량부, 코카마이도프로필베타인 6 내지 8 중량부, 코카마이드디이에이 6 내지 8 중량부, 아이오도프로피닐부틸카바메이트 0.03 내지 0.05 중량부, 글라이콜디스테아레이트 0.3 내지 0.5 중량부, 세트리모늄클로라이드 1.8 내지 2.2 중량부, 향료 0.3 내지 0.7 중량부, 트리에탄올아민 0.3 내지 0.7 중량부, 소듐클로라이드 0.3 내지 0.7 중량부, 하이드롤라이즈드케라틴 0.8 내지 1.2 중량부, 하수오추출물 0.13 내지 0.15 중량부, 홍삼추출물 0.13 내지 0.15 중량부, 백지추출물 0.13 내지 0.15 중량부, 한련초추출물 0.13 내지 0.15 중량부, 당귀추출물 0.13 내지 0.15 중량부, 석류추출물 0.13 내지 0.15 중량부, 대황추출물 0.13 내지 0.15 중량부, 카퍼트리펩타이드 0.15 내지 0.25 중량부, 그라비올라 에탄올 추출물 0.4 내지 0.6 중량부, 소듐라우에스에테르설페이트 23 내지 27 중량부 및 그라비올라 열수추출물 23 내지 27중량부로 혼합하는 것을 특징으로 하는 방법을 제공하는데, 보다 상세하게는, 정제수 15 중량부, 카보너 0.2 중량부, 디소듐이디티에이 0.07 중량부, 시크릭애씨드 0.2 중량부, 솔잣나무열매추출물 0.2 중량부, 글리세린 1.7 중량부, 디메치콘 2 중량부, 소듐라우릴설페이트 10 중량부, 코카마이도프로필베타인 7 중량부, 코카마이드디이에이 7 중량부, 아이오도프로피닐부틸카바메이트 0.04 중량부, 글라이콜디스테아레이트 0.4 중량부, 세트리모늄클로라이드 2 중량부, 향료 0.5 중량부, 트리에탄올아민 0.5 중량부, 소듐클로라이드 0.5 중량부, 하이드롤라이즈드케라틴 1 중량부, 하수오추출물 0.143 중량부, 홍삼추출물 0.143 중량부, 백지추출물 0.143 중량부, 한련초추출물 0.143 중량부, 당귀추출물 0.143 중량부, 석류추출물 0.143 중량부, 대황추출물 0.143 중량부, 카퍼트리펩타이드 0.2 중량부, 그라비올라 에탄올추출물 0.5 중량부, 소듐라우에스에테르설페이트 25 중량부 및 그라비올라 열수추출물 25 중량부로 혼합하는 것을 특징으로 하는 방법을 제공한다.In order to achieve the object of the present invention, in one embodiment, the present invention provides a method for preparing a cosmetic composition having an antioxidant effect, a whitening effect, an anti-wrinkle effect and an anti-inflammatory effect, comprising the following steps: 1) purified water, carbo Filtration after dissolving the mer and disodium EDTA by heating to 90° C.; 2) cyclonic acid, pine needle fruit extract, glycerin, dimethicone, sodium lauryl sulfate and cocamidopropyl betaine were dissolved by heating to 70° C., followed by mixing and stirring with the filtrate of step 1); 3) Cocamide DEA, iodopropynyl butyl carbamate and glycol distearate were dissolved by heating to 70°C, filtered, mixed with the product of step 2), and cooled to 60°C; 4) Cetrimonium chloride, fragrance, triethanolamine, sodium chloride, hydrolyzed keratin, sewage extract, red ginseng extract, white paper extract, orchid extract, Angelica asiatica extract, pomegranate extract, rhubarb extract, copper tripeptide, graviola ethanol extract, A step of mixing and stirring sodium laureth ether sulfate and graviola hot water extract with the product of step 3) is provided, cooling to 60° C. and filtering. In the above embodiment, 13 to 17 parts by weight of purified water, 0.1 to 0.3 parts by weight of carbonner, 0.05 to 0.1 parts by weight of disodium EDTA, 0.1 to 0.3 parts by weight of citric acid, 0.1 to 0.3 parts by weight of pine needle fruit extract, Glycerin 1.5 to 2.0 parts by weight, dimethicone 1.5 to 2.5 parts by weight, sodium lauryl sulfate 8 to 12 parts by weight, cocamidopropyl betaine 6 to 8 parts by weight, cocamide DA 6 to 8 parts by weight, iodopropy 0.03-0.05 parts by weight of nylbutyl carbamate, 0.3-0.5 parts by weight of glycol distearate, 1.8-2.2 parts by weight of cetrimonium chloride, 0.3-0.7 parts by weight of fragrance, 0.3-0.7 parts by weight of triethanolamine, 0.3 parts by weight of sodium chloride to 0.7 parts by weight, hydrolyzed keratin 0.8 to 1.2 parts by weight, sewage extract 0.13 to 0.15 parts by weight, red ginseng extract 0.13 to 0.15 parts by weight, white paper extract 0.13 to 0.15 parts by weight, chrysanthemum extract 0.13 to 0.15 parts by weight, Angelica Root extract 0.13 to 0.15 parts by weight, pomegranate extract 0.13 to 0.15 parts by weight, rhubarb extract 0.13 to 0.15 parts by weight, copper tripeptide 0.15 to 0.25 parts by weight, graviola ethanol extract 0.4 to 0.6 parts by weight, sodium laureth ether sulfate 23 to 27 weight It provides a method, characterized in that it is mixed in parts and 23 to 27 parts by weight of the graviola hot water extract, more specifically, 15 parts by weight of purified water, 0.2 parts by weight of carboner, 0.07 parts by weight of disodium EDTA, cyclonic acid 0.2 parts by weight, pine needle fruit extract 0.2 parts by weight, glycerin 1.7 parts by weight, dimethicone 2 parts by weight, sodium lauryl sulfate 10 parts by weight, cocamidopropyl betaine 7 parts by weight, cocamide DA 7 parts by weight, IO 0.04 parts by weight of dopropynyl butyl carbamate, 0.4 parts by weight of glycol distearate, 2 parts by weight of cetrimonium chloride, 0.5 parts by weight of fragrance, 0.5 parts by weight of triethanolamine, 0.5 parts by weight of sodium chloride parts by weight, hydrolyzed keratin 1 part by weight, sewage extract 0.143 parts by weight, red ginseng extract 0.143 parts by weight, white paper extract 0.143 parts by weight, orchid extract 0.143 parts by weight, Angelica root extract 0.143 parts by weight, pomegranate extract 0.143 parts by weight, rhubarb extract 0.143 parts by weight, 0.2 parts by weight of copper tripeptide, 0.5 parts by weight of graviola ethanol extract, 25 parts by weight of sodium laureth ether sulfate and 25 parts by weight of graviola hot water extract.

본 발명의 다른 일 구체예에서는 상기 구체예에서 제조된 생성물을 유효성분으로 포함하는 항산화효과, 미백효과, 주름개선효과 및 항염증 효과가 있는 화장료 조성물을 제공한다. In another embodiment of the present invention, there is provided a cosmetic composition having an antioxidant effect, a whitening effect, an anti-wrinkle effect, and an anti-inflammatory effect, comprising the product prepared in the above embodiment as an active ingredient.

본 발명에 따른 탈모 방지 및 두피 개선용 모발 화장료 조성물은 인체 친화적 천연 화장품으로서, 세포독성이 낮고 항균력이 있는 그라비올라 추출물을 포함하고 있어서 인체 피부에 무해하고 민감성 피부를 가진 사람에게도 쉽게 사용할 수 있다. 또한, 모발 성장 촉진에 효과적으로 작용하고, 두피 모근을 자극해 탈모예방에도 도움을 줄 뿐만 아니라 모발을 효과적으로 생장시킬 수 있는 장점이 있다.The hair cosmetic composition for preventing hair loss and improving scalp according to the present invention is a human-friendly natural cosmetic, containing graviola extract with low cytotoxicity and antibacterial activity, so it is harmless to human skin and can be easily used even by people with sensitive skin. In addition, it effectively acts to promote hair growth, stimulates the scalp hair root, helps prevent hair loss, and has the advantage of effectively growing hair.

또한, 항산화효과, 미백효과, 주름개선효과 및 항염증 효과가 있다.In addition, it has an antioxidant effect, a whitening effect, an anti-wrinkle effect, and an anti-inflammatory effect.

도 1 내지 도 4는 그라비올라 추출물의 항산화 효과를 측정한 결과를 나타낸 것이다.
도 5는 그라비올라 추출물의 세포 독성을 측정한 결과를 나타낸 것이다.
도 6은 그라비올라 추출물의 티로시나아제 저해능을 측정한 결과를 나타낸 것이다.
도 7은 그라비올라 추출물의 프로콜라겐 합성에 대한 효과를 나타낸 것이다.
도 8은 그라비올라 추출물의 항균력을 측정한 결과를 나타낸 것이다.
도 9는 그라비올라 추출물의 항균 펩타이드 합성에 대한 효과를 나타낸 것이다.
도 10은 그라비올라 추출물의 주름개선효과를 엘라스타제 저해능에 의해 측정한 결과를 나타낸 것이다.
도 11 및 도 12는 그라비올라 추출물의 항염증 효과를 측정한 결과를 나타낸 것이다.
1 to 4 show the results of measuring the antioxidant effect of the graviola extract.
5 shows the results of measuring the cytotoxicity of the graviola extract.
6 shows the results of measuring the tyrosinase inhibitory ability of the graviola extract.
7 shows the effect of the graviola extract on procollagen synthesis.
8 shows the results of measuring the antimicrobial activity of the graviola extract.
9 shows the effect of the graviola extract on the synthesis of antibacterial peptides.
10 shows the results of measuring the wrinkle improvement effect of the graviola extract by the elastase inhibitory ability.
11 and 12 show the results of measuring the anti-inflammatory effect of the graviola extract.

이하, 본 발명의 구성요소와 기술적 특징을 다음의 실시예들을 통하여 보다 상세하게 설명하고자 한다. 그러나 하기 실시예들은 본 발명의 내용을 예시하는 것일 뿐 발명의 범위가 실시예에 의해 한정되는 것은 아니다.Hereinafter, the components and technical features of the present invention will be described in more detail through the following examples. However, the following examples are merely illustrative of the content of the present invention, and the scope of the present invention is not limited by the examples.

실시예Example

추출물의 제조Preparation of extracts

1.1 그라비올라 에탄올 추출물1.1 Graviola Ethanol Extract

그라비올라잎 및 에탄올(70%)을 1:100 중량비로 혼합하여 24H 롤링 추출기에서 추출물을 제조하였다. 제조된 추출물은 건조시켜 파우더로 만들었다. Graviola leaves and ethanol (70%) were mixed in a weight ratio of 1:100 to prepare an extract in a 24H rolling extractor. The prepared extract was dried and made into a powder.

1.2 그라비올라 열수 추출물1.2 Graviola Hot Water Extract

그라비올라잎 및 화장품 정제수를 1:200 중량비로 100℃까지 열탕하여 추출물을 제조하였다.An extract was prepared by boiling graviola leaves and cosmetic purified water at a weight ratio of 1:200 to 100°C.

1.3 단오수 추출물1.3 Danose Water Extract

대황, 한련초, 하수오, 백지 석류, 인삼, 당귀를 부틸렌글리콜과 글리세린 혼합하여 수용액으로 제조한 후 70℃ 내지 80℃에서 중탕하였다. 1㎛ 필터로 여과를 실시한 후 방냉하여 상온에 방치하였다. 0.8 ㎛ 및 0.45 ㎛ 필터로 2차 여과를 실시한 후 방부제를 처리한 후 0.2 ㎛ 필터로 3차 여과를 실시하였다.Rhubarb, chrysanthemum, rhododendron, white pomegranate, ginseng and angelica were mixed with butylene glycol and glycerin to prepare an aqueous solution, followed by hot water bathing at 70°C to 80°C. After filtering with a 1 μm filter, it was allowed to cool and left at room temperature. After performing secondary filtration with 0.8 μm and 0.45 μm filters, preservatives were treated, and then tertiary filtration was performed with 0.2 μm filters.

효능 테스트efficacy test

2.1 항산화 효과2.1 Antioxidant effect

1) DPPH 라디칼 소거능1) DPPH radical scavenging ability

DPPH 전자공여능은 Blois의 방법(비특허문헌 1)에 따라 측정하였다. 그라비올라 추출물을 포함하는 각 시료용액 2 mL에 0.2 mM 의 1,1-디페닐-2-피크릴히드라질(DPPH) 1 mL를 넣고 교반하였다. 30분간 방치한 후 517 nm에서 흡광도를 측정하였다. 전자공여능은 시료용액의 첨가구와 무첨가군의 흡광도 감소율로 나타내었다. 그라비올라 열수추출물 및 에탄올추출물에 대한 DPPH 라디칼 소거능 측정결과, 그라비올라 에탄올추출물 1,000 ug/ml에서 양성대조군 비타민-C(Vit-C)보다 우수한 효능효과를 확인하였다(도 1, 열수추출물 79%, 에탄올추출물 91%, 비타민 C 83%).DPPH electron donating ability was measured according to the method of Blois (Non-Patent Document 1). To 2 mL of each sample solution containing the graviola extract, 1 mL of 0.2 mM 1,1-diphenyl-2-picrylhydrazyl (DPPH) was added and stirred. After standing for 30 minutes, absorbance was measured at 517 nm. The electron donating ability was expressed as the absorbance decrease rate of the addition and non-addition groups of the sample solution. As a result of measuring the DPPH radical scavenging ability of the graviola hot water extract and the ethanol extract, 1,000 ug/ml of the graviola ethanol extract confirmed a superior efficacy than the positive control group vitamin-C (Vit-C) (Fig. 1, hot water extract 79%, Ethanol extract 91%, vitamin C 83%).

2) ABTS 양이온 라디칼 소거능 2) ABTS cation radical scavenging ability

ABTS (2,2'-azino-bis(3-ethylbenzthiazoline)-6-sulphonic acid) 양이온 라디칼을 이용한 항산화력 측정은 ABTS 양이온 탈색 시험(비특허 문헌 2)에 의하여 측정하였다. 7mM 2,2-아지노-비스(3-에틸벤즈티아졸린)-6-술폰산(ABTS)와 2.4mM 과황산칼륨(Potassium persulfate)를 최종 농도로 혼합하여 실온인 암소에서 24시간 동안 방치하여 ABTS+를 형성시킨 후 인산염 완충 식염수(PBS)로 희석하여 ABTS+ 100 uL를 가하여 1분 동안 방치한 후 732 nm에서 흡광도를 측정하였다. 그라비올라 열수추출물 및 그라비올라 에탄올추출물의 ABTS+ 라디칼 소거능 측정결과, 그라비올라 에탄올추출물 500 ㎍/㎖에서 양성대조군 비타민-C보다 우수한 효능효과를 확인하였다(도 2).The antioxidative power measurement using the ABTS (2,2'-azino-bis(3-ethylbenzthiazoline)-6-sulphonic acid) cation radical was measured by the ABTS cation decolorization test (Non-Patent Document 2). 7mM 2,2-azino-bis(3-ethylbenzthiazoline)-6-sulfonic acid (ABTS) and 2.4mM potassium persulfate were mixed to a final concentration and left for 24 hours in a dark place at room temperature to add ABTS + After forming a phosphate buffered saline (PBS) diluted with ABTS + 100 uL was added, left for 1 minute, and then absorbance was measured at 732 nm. As a result of measuring the ABTS + radical scavenging ability of the graviola hot water extract and the graviola ethanol extract, 500 μg/ml of the graviola ethanol extract confirmed the superior efficacy than the positive control group vitamin-C (FIG. 2).

3) 슈퍼옥사이드 음이온 라디칼(superoxide anion radical) 소거능 3) Superoxide anion radical scavenging ability

슈퍼옥사이드 음이온 라디칼 소거능은 NBT(nitrobule tetrazolium) 환원방법에 의해 측정하였다(비특허문헌 3). 각 시료용액 0.1 mL와 0.1M 칼륨 포스페이트 완충액(pH 7.5) 0.4 mL에 잔틴(Xanthine) 0.4 mM 과 NBT(0,24 mM)을 녹인 기질액 1 mL을 첨가하고 잔틴 산화효소(0,2 U/ML) 1ML를 가하여 37℃에서 20분간 반응시킨 후 1 N 염산 1 mL을 가하여 반응을 종료시켰다. 반응액 중에 생성된 슈퍼옥사이드 음이온 라디칼의 양은 560 nm에서의 흡광도에 의해 측정하였다. 그라비올라 열수추출물 및 그라비올라 에탄올추출물의 superoxide anion radical 소거능 측정결과, 그라비올라 열수추출물 1,000 ㎍/㎖에서 양성대조군 Vit-C 보다 우수한 효능효과를 확인하였다(도 3).Superoxide anion radical scavenging ability was measured by NBT (nitrobule tetrazolium) reduction method (Non-Patent Document 3). To 0.1 mL of each sample solution and 0.4 mL of 0.1M potassium phosphate buffer (pH 7.5), add 1 mL of a substrate solution in which 0.4 mM Xanthine and NBT (0,24 mM) were dissolved, and xanthine oxidase (0,2 U/ ML) 1 ML was added, followed by reaction at 37° C. for 20 minutes, and then 1 mL of 1 N hydrochloric acid was added to terminate the reaction. The amount of superoxide anion radicals generated in the reaction solution was measured by absorbance at 560 nm. As a result of measuring the superoxide anion radical scavenging activity of the graviola hot water extract and the graviola ethanol extract, 1,000 μg/ml of the graviola hot water extract showed a superior efficacy than the positive control group Vit-C (FIG. 3).

4) 슈퍼옥사이드 디스뮤타제(SOD) 유사 활성능4) Superoxide dismutase (SOD)-like activity

SOD 유사활성은 Marklund의 방법(비특허문헌 4)에 따라 측정하였다. 각 시료용액 0.2ML에 Tris-HCl의 완충용액 (50 mM Tris+10 mM EDTA, pH 8.5) 2.6ML와 7.2 MM 피로갈롤(pyrogallol)의 양을 420 nm에서 측정하였다. SOD 유사활성은 시료용액의 실험구와 대조구의 흡광도 감소율로 나타내었다. 그라비올라 열수추출물 및 그라비올라 에탄올추출물 1,000ug/ml에서 각 10.27%, 22.2%의 효능효과를 확인하였다(도 4). 활성산소와 인체내 독성을 제거하는 항산화효소의 활성도를 측정한 것으로 항산화력은 우수하게 측정되었으나 SOD(항산화효소)의 활성도는 비타민 C에 비하여 현저히 낮게 나타났다.SOD-like activity was measured according to Marklund's method (Non-Patent Document 4). In 0.2 mL of each sample solution, 2.6 mL of Tris-HCl buffer (50 mM Tris+10 mM EDTA, pH 8.5) and 7.2 mM pyrogallol were measured at 420 nm. The SOD-like activity was expressed as the absorbance reduction rate of the experimental group and the control group of the sample solution. At 1,000 ug/ml of graviola hot water extract and graviola ethanol extract, efficacy effects of 10.27% and 22.2% were confirmed, respectively (FIG. 4). The activity of antioxidant enzymes that remove free radicals and toxins in the human body was measured. The antioxidant power was excellent, but the activity of SOD (antioxidant enzyme) was significantly lower than that of vitamin C.

2.2 세포 독성2.2 Cytotoxicity

본 발명에서 각 세포의 배양은 10% fetal bovine serum (FBS)과 을 첨가한 Dulbeco's modified eagle's medium (DMEM) 배지를 사용하였으며, 37℃, 5% CO2 incubator에 적응시켜 계대 배양하였다.In the present invention, each cell was cultured using 10% fetal bovine serum (FBS) and Dulbeco's modified eagle's medium (DMEM) medium supplemented with , and subcultured at 37° C., adapted to a 5% CO2 incubator.

세포 생존율 측정은 Camichael의 방법(비특허문헌 5)에 따라 실시하였다. 세포 생존율을 확인하기 위한 MTT 검색법은 96 well plate를 사용하며 ELISA reader (multiwell microplate reader)를 이용하여 많은 시료를 간단하게 판독할 수 있어 세포독성 및 세포증식 검색법으로서 널리 사용되고 있는 방법 중의 한 방법이다. 각 세포 melanoma (B16F10), fibroblast (CCRF), macrophage (Raw264.7) cell를 96 well plate에 0.6~8x103 cells/well이 되게 0.18 mL 분주하고 시료를 농도 별로 조제하여 0.02 mL 첨가한 후 37℃ , 5% CO2 incubator에서 24시간 배양하였다. 대조군은 시료와 동량의 멸균수를 첨가하여 동일한 조건으로 배양하였다. 여기에 5 mg/mL 농도로 제조한 MTT 용액 0.02 mL를 첨가하여 4시간 배양한 후 배양액을 제거하고 각 well당 DMSO: Ethanol (1: 1) 0.15 mL를 가하여 실온에서 30분간 반응시킨 뒤 ELISA reader로 550 nm에서 흡광도를 측정하였다. 세포 생존율 측정은 시료 용액의 첨가군과 무첨가군의 흡광도 감소율로 나타내었다. MTT assay (B16F10 melanoma) 실험결과 그라비올라 열수추출물은 10ug/ml 농도에서 세포 생존율이 80% 이상으로 확인하였으며, 그라비올라 에탄올추출물은 1ug/ml 농도에서 80% 이상의 세포생존율을 확인하였다(도 5).Cell viability was measured according to Camichael's method (Non-Patent Document 5). The MTT screening method to check the cell viability uses a 96-well plate and can easily read many samples using an ELISA reader (multiwell microplate reader), which is one of the methods widely used as a cytotoxicity and cell proliferation screening method. to be. Each cell melanoma (B16F10), fibroblast (CCRF), macrophage (Raw264.7) cells were dispensed in a 96-well plate at a volume of 0.6~8x10 3 cells/well, and 0.18 mL of each sample was prepared by concentration, added 0.02 mL, and then added at 37°C. , 5% CO 2 Incubated for 24 hours in an incubator. The control group was cultured under the same conditions by adding the same amount of sterile water as the sample. Here, 0.02 mL of MTT solution prepared at a concentration of 5 mg/mL was added, incubated for 4 hours, the culture medium was removed, and 0.15 mL of DMSO: Ethanol (1: 1) was added to each well, reacted at room temperature for 30 minutes, and then ELISA reader Absorbance was measured at 550 nm. Cell viability was measured as a decrease in absorbance of the group with and without the addition of the sample solution. As a result of the MTT assay (B16F10 melanoma) test, the graviola hot water extract showed a cell viability of 80% or more at a concentration of 10 ug/ml, and the graviola ethanol extract confirmed a cell viability of 80% or more at a concentration of 1 ug/ml (FIG. 5) .

2.3 미백 효과2.3 Whitening effect

1) 버섯 유래의 티로시나아제 저해능 1) Inhibitory ability of mushroom-derived tyrosinase

티로시나아제 저해능 측정은 Yagi 등(비특허문헌 6)의 방법에 따라 측정하였다. 반응구는 0.175 M 인산나트륨 완충액 (pH 6.8) 0.5 mL에 10 mM L-DOPA를 녹인 기질 액 0.2 mL 및 시료용액 0.1 mL의 혼합액에 버섯 티로시나아제 (110 U/mL) 0.2 mL를 첨가하여 37?에서 2분간 반응시켜 반응 액 중에 생성된 DOPA chrome을 475 nm에서 측정하였다. 티로시나아제 저해능은 시료용액의 첨가구와 무 첨가 군의 흡광도 감소율로 나타내었다(도 6).Tyrosinase inhibitory ability was measured according to the method of Yagi et al. (Non-Patent Document 6). The reaction zone is a mixture of 0.2 mL of a substrate solution in which 10 mM L-DOPA is dissolved in 0.5 mL of 0.175 M sodium phosphate buffer (pH 6.8) and 0.1 mL of the sample solution by adding 0.2 mL of mushroom tyrosinase (110 U/mL) to 37? At 475 nm, the DOPA chrome produced in the reaction solution was measured at 475 nm by reacting for 2 minutes. The tyrosinase inhibitory ability was expressed as the absorbance reduction rate of the group with and without the addition of the sample solution (FIG. 6).

2) B16F10에서의 멜라닌(melanin) 생합성 저해능2) Inhibition of melanin biosynthesis in B16F10

멜라닌 생합성 저해능 측정은 Hosoi의 방법(비특허문헌 7)에 따라 측정하였다. DMEM 배지로 배양된 melanoma cell을 100 mm culture dish에 2 x 106 cell/dish가 되게 분주하고 24시간 배양 후 시료를 농도별로 조제하여 2 mL 첨가하고, 48시간 후에 PBS (pH 7.4)으로 세척하였다. 그 다음 0.25 M trypsin-EDTA 용액으로 세포를 탈착한 후 수확한 세포를 1 x 106 세포 당 1 mL의 5% TCA로 처리하고, 2,500 rpm으로 2회 원심분리 한 후 분리된 melanin을 PBS으로 세척한 뒤 에테르: 에탄올 (1:3) 1 mL를 가하여 2회 원심 분리한 후 에테르 1 mL로 세척 건조시켰다. 건조된 멜라닌에 1 N NaOH를 1 mL 가하여 80?에서 1시간 반응시킨 후 분광 광도계 405 nm에서 흡광도를 측정하였다. 멜라닌 생합성 저해는 시료용액의 첨가군과 무첨가군의 흡광도 감소율로 나타내었다.Melanin biosynthesis inhibitory ability was measured according to the method of Hosoi (Non-Patent Document 7). The melanoma cells cultured in DMEM medium were aliquoted to 2 x 10 6 cells/dish in a 100 mm culture dish. After culturing for 24 hours, samples were prepared by concentration, 2 mL was added, and washed with PBS (pH 7.4) after 48 hours. . Then, after detaching the cells with 0.25 M trypsin-EDTA solution, the harvested cells were treated with 1 mL of 5% TCA per 1 x 10 6 cells, centrifuged twice at 2,500 rpm, and the separated melanin was washed with PBS. Then, 1 mL of ether: ethanol (1:3) was added, centrifuged twice, and washed and dried with 1 mL of ether. 1 mL of 1 N NaOH was added to the dried melanin, reacted at 80° C. for 1 hour, and absorbance was measured at 405 nm spectrophotometer. Inhibition of melanin biosynthesis was expressed as a decrease in absorbance in the group with and without the sample solution.

3) 프로-콜라겐 합성 속도3) Pro-collagen synthesis rate

그라비올라 추출물의 프로콜라겐 합성에 대한 효과를 측정하였다(도 7).The effect of the graviola extract on procollagen synthesis was measured (FIG. 7).

2.4 항균력2.4 Antibacterial

전 배양 및 본 배양을 위한 액체 배지는 Staphylococcus epidermidis (S. epidermidis) 및 Escherichia coli (E.coli)의 액체배지로는 nutrient broth (NB)를 Staphylococcus aureus (S. aureus)의 액 체 배지로는 tryptic soy broth (TSB)를 사용했고, Propionibacterium acnes (P. acnes) 균은 Gifu anaerobic medium (GAM)배지를 사용했다. S. epidermidis 및 E. coli의 고체배지는 nutrient agar (NA)를 사용했으며, S. aureus의 액체배지로는 tryptic soy agar (TSA)를 사용하여 배양했으며, P.acnes균은 Gifu anaerobic medium (GAM) 배지에 agar를 첨가하여 본 실험에 사용하였다. P.acnes 균은 5%, CO2 incubator에서 37℃로 배양하였고, 그 외의 모든 균주는 BOD incubator에서 37℃로 배양하였다.The liquid medium for pre-culture and main culture was nutrient broth (NB) as a liquid medium for Staphylococcus epidermidis (S. epidermidis) and Escherichia coli (E. coli) and tryptic as a liquid medium for Staphylococcus aureus (S. aureus). Soy broth (TSB) was used, and for Propionibacterium acnes (P. acnes), Gifu anaerobic medium (GAM) medium was used. Nutrient agar (NA) was used for the solid medium of S. epidermidis and E. coli, and tryptic soy agar (TSA) was used as the liquid medium for S. aureus, and P.acnes was cultured using Gifu anaerobic medium (GAM). ) was used in this experiment by adding agar to the medium. P.acnes bacteria were cultured at 37°C in a 5% CO2 incubator, and all other strains were cultured at 37°C in a BOD incubator.

그라비올라 열수 추출물의 항균력을 테스트하였다. 대조군으로는 일반 정제수를 사용하였다. 황색포도상구균(Staphylococcus aureus), 대장균(E. coli)을 그라비올라 수 및 일반 정제수가 포함된 배지에서 4주간 배양하여 항균력을 확인하였다. 항균력 측정은 paper disc법으로 측정하였다. 평판 배지에 single colony 배양된 각 균주를 1 백금이를 취해서 액체배지 10 mL에서 18~24시간 배양하여 활성화시킨 후, 다시 액체배지 10 mL에 균액을 0.1 mL접종하여 3~6시간 본 배양한 후 평판배지 1개당 균수가 약 1×107 cells이 되게 접종하여 멸균 면봉으로 균일하게 도말하였다. 멸균된 filter paper disc (8 mm, Whatman, Japan)를 고체 평판배지에 올려놓은 다음 50 μL/disc가 되도록 시료를 농도별로 흡수시켜 37℃에서 18~24시간 배양하여 disc 주위의 clear zone (mm)의 직경을 측정하였다(도 8). The antibacterial activity of graviola hot water extract was tested. As a control, normal purified water was used. Staphylococcus aureus and E. coli were cultured in a medium containing graviola water and general purified water for 4 weeks to confirm the antibacterial activity. Antibacterial activity was measured by the paper disc method. 1 Platinum lice of each strain cultured as a single colony on a plate medium was taken and cultured in 10 mL of liquid medium for 18 to 24 hours for activation. The number of bacteria per plate medium was inoculated to about 1×107 cells and spread evenly with a sterile cotton swab. After placing a sterilized filter paper disc (8 mm, Whatman, Japan) on a solid plate medium, absorb the samples by concentration so as to become 50 μL/disc, incubate at 37°C for 18 to 24 hours, and clear zone (mm) around the disc. was measured (Fig. 8).

2.5 항균 펩타이드의 발현2.5 Expression of Antimicrobial Peptides

그라비올라 추출물을 인간 피부각질세포(keratinocyte)에 처리한 후, 피부세포 자체에서 발현되는 항균 펩타이드인 CAMP(Cathelicidin antimicrobial peptide) 및 LL-37의 발현을 확인하였다. MITF, TRP-1, TRP-2, MMP-1, iNOS, COX-2 활성을 확인하기 위하여 cell line (B16F10, CCRF, Raw246.7)을 tissue culture dish에 cell seeding 후 24시간 동안 배양하여 cell을 안정화시켰다. 배지를 제거한 후 시료를 농도별로 처리한 배지로 24~48시간 배양한 후 다시 배지를 제거하고 PBS로 2번 세척해주었다. RIPA buffer 10 ml에 complete mini 1 tab를 가하여 100 uL로 용해해서 4℃, 12,000 rpm에서 20분간 원심 분리하였다. 원심 분리하여 얻은 단백질은 bovine serum albumin (BSA)를 표준물질로 하여 Bradford assay로 정량하였으며, 10% SDS-polyacrylamide gel을 이용하여 120 V에서 1시간 전기영동 한다. loading이 끝나면 polyvinylidenedifluoriden (PVDF)을 사용하여 30~40 V에서 2시간 이상 transfer 하였다. transfer가 끝나면 ponceau S에 담근 후 band를 확인하고 TBST로 2회 이상 세척한 후 5% skin milk로 overnight 시켜 background는 제거시켰다. 3회 washing 후에 1차 antibody (1: 1000)를 1시간 동안 붙인 후 2차 antibody (1: 1000)를 붙이고 ECL kit (Amersham Pharmacia, England)를 이용하여 film에 옮겨 측정하였다. Band density는 Gel doc (Bio-rad, America)으로 확인하였다(도 9). After the graviola extract was treated on human keratinocytes, the expression of Cathelicidin antimicrobial peptide (CAMP) and LL-37, which are antibacterial peptides expressed in the skin cells themselves, was confirmed. In order to check the activity of MITF, TRP-1, TRP-2, MMP-1, iNOS, and COX-2, cell lines (B16F10, CCRF, Raw246.7) were seeded in a tissue culture dish and then cultured for 24 hours. stabilized. After removing the medium, the sample was incubated for 24 to 48 hours with a medium treated for each concentration, the medium was removed again, and washed twice with PBS. Complete mini 1 tab was added to 10 ml of RIPA buffer, dissolved in 100 uL, and centrifuged at 4°C and 12,000 rpm for 20 minutes. Proteins obtained by centrifugation were quantified by Bradford assay using bovine serum albumin (BSA) as a standard, and electrophoresed at 120 V for 1 hour using 10% SDS-polyacrylamide gel. After loading, polyvinylidenedifluoriden (PVDF) was used for transfer at 30-40 V for 2 hours or more. After transfer, the band was checked after immersion in ponceau S, washed twice or more with TBST, and incubated overnight with 5% skin milk to remove the background. After washing 3 times, the primary antibody (1: 1000) was attached for 1 hour, the secondary antibody (1: 1000) was attached and transferred to the film using an ECL kit (Amersham Pharmacia, England) for measurement. Band density was confirmed by Gel doc (Bio-rad, America) (FIG. 9).

2.6 주름개선 효과 2.6 Wrinkle improvement effect

엘라스타아제(Elastase) 저해능 측정에 의해 그라비올라 추출물의 주름개선 효과를 측정하였다. Elastase 저해능 측정은 Cannell 등(비특허문헌 7)의 방법에 따라 측정하였다. 기질로서 N-succinyl-(L-Ala)3-p-nitroanilide를 사용하여 37?에서 20분간 기질로부터 생성되는 p-nitroanilide의 생성량을 405 nm에서 측정하였다. 즉, 각 시험용액을 일정 농도가 되도록 조제하여 0.5 mL씩 시험관에 취하고, 50 mM tris-HCl buffer (pH 8.6)에 녹인 porcine pancreas elastase (2.5 U/mL)용액 0.5 mL을 가한 후 기질로 50 mM tris-HCl buffer (pH 8.6)에 녹인 N-succinyl-(L-Ala)3-p-nitroanilide (0.5 mg/mL)을 첨가하여 20분간 반응시켜 측정하였다. elastase 저해능은 시료용액의 첨가구와 무 첨가 군의 흡광도 감소율로 나타내었다(도 10).The wrinkle improvement effect of the graviola extract was measured by measuring the elastase inhibitory ability. Elastase inhibitory ability was measured according to the method of Cannell et al. (Non-Patent Document 7). Using N-succinyl-(L-Ala)3-p-nitroanilide as a substrate, the amount of p-nitroanilide produced from the substrate was measured at 405 nm at 37°C for 20 minutes. That is, prepare each test solution to a certain concentration, take 0.5 mL of each test tube, add 0.5 mL of porcine pancreas elastase (2.5 U/mL) solution dissolved in 50 mM tris-HCl buffer (pH 8.6), and then add 50 mM as a substrate N-succinyl-(L-Ala)3-p-nitroanilide (0.5 mg/mL) dissolved in tris-HCl buffer (pH 8.6) was added, followed by reaction for 20 minutes. The elastase inhibitory ability was expressed as the absorbance reduction rate of the group with and without the addition of the sample solution (FIG. 10).

2.7 항염증 효과2.7 Anti-inflammatory effect

Nitric oxide (NO) 측정은 cell의 supernatant에서의 NO의 량을 nitrite and nitrate로서 측정을 하였다(비특허문헌 8). Nitrite에 대한 nitrate로 환원된 후의 안전한 형태인 griess reagent (Sigma, USA)를 사용하였으며, 6 well plate에 2×106개의 cell을 confluence가 80%일 때, PBS로 2번 washing한 후 무혈청 배지를 사용하여 12시간 이상 배양시킨 다음 lipopolysacchride (LPS) 10 μg/mL을 control 군을 뺀 모든 well에 다 넣어서 자극시켰다. 2시간 후에 시료를 농도별로 처리하여 실험하였다. NO 생성량은 24시간 후에 상층액을 모아 griess regent로 10분간 반응시킨 후에 540 nm에서 흡광도로 측정하였다(도 11). 또한, 그라비올라 추출물의 iNOS 발현 억제효과를 측정하였다(도 12).Nitric oxide (NO) was measured as nitrite and nitrate in the amount of NO in the supernatant of the cell (Non-Patent Document 8). Griess reagent (Sigma, USA), which is a safe form after reduction with nitrate for nitrite, was used. When confluence was 80%, 2 × 106 cells in a 6 well plate were washed twice with PBS and then serum-free medium was used. After incubation for more than 12 hours, 10 μg/mL of lipopolysacchride (LPS) was added to all wells except the control group and stimulated. After 2 hours, samples were treated by concentration and tested. The amount of NO production was measured by absorbance at 540 nm after collecting the supernatant after 24 hours and reacting with griess regent for 10 minutes (FIG. 11). In addition, the iNOS expression inhibitory effect of the graviola extract was measured (FIG. 12).

모발 화장료 조성물의 제조Preparation of hair cosmetic composition

본 발명에 따른 모발 화장료 조성물 100 중량부를 기준으로, 1) 카보머 0.2 중량부 및 디소듐이디티에이 0.07 중량부를 정제수 15 중량부에 넣고 90℃까지 가온하여 용해시켰다. 용해물에 대하여 여과를 실시하였다; 2) 시트릭애씨드 0.2 중량부, 솔잣나무열매추출물 0.2 중량부, 글리세린 1.7 중량부, 디메치콘 2 중량부, 소듐라우릴설페이트 10 중량부 및 코카마이도프로필베타인 7 중량부를 혼합하여 70℃까지 가온하여 용해시킨 후 상기 1) 단계의 여과물과 혼합 교반하였다; 3) 코카마이드디에이 7 중량부, 아이오도프로피닐부틸카바메이트 0.04 중량부 및 글라이콜디스테아레이트 0.4 중량부를 70℃까지 가온하여 용해시키고 여과하여 상기 단계 2)의 생성물과 혼합 교반한 후, 60℃까지 냉각하였다; 4) 세트리모늄클로라이드 2 중량부, 향료 0.5 중량부, 트리에탄올아민 0.5 중량부, 소듐클로라이드 0.5 중량부, 하이드롤라이즈드케라틴 1 중량부, 하수오추출물 0.143 중량부, 홍삼추출물 0.143 중량부, 백지추출물 0.143 중량부, 한련초추출물 0.143 중량부, 당귀추출물 0.143 중량부, 석류추출물 0.143 중량부, 대황추출물 0.143 중량부, 카퍼트리펩타이드 0.2 중량부, 그라비올라추출물 0.5 중량부, 소듐라우레스에테르설페이트 25 중량부 및 정제수 대체(그라비올라 수) 25 중량부를 상기 단계 3)의 60℃로 냉각된 혼합물과 혼합교반하여 35℃까지 냉각한 후 여과시켜 모발 화장료 조성물을 제조하였다. Based on 100 parts by weight of the hair cosmetic composition according to the present invention, 1) 0.2 parts by weight of Carbomer and 0.07 parts by weight of Disodium EDITA were placed in 15 parts by weight of purified water and dissolved by heating to 90°C. The lysate was filtered; 2) Mix 0.2 parts by weight of citric acid, 0.2 parts by weight of pine needle fruit extract, 1.7 parts by weight of glycerin, 2 parts by weight of dimethicone, 10 parts by weight of sodium lauryl sulfate and 7 parts by weight of cocamidopropyl betaine until 70° C. After dissolution by heating, the mixture was stirred with the filtrate of step 1); 3) 7 parts by weight of cocamide DA, 0.04 parts by weight of iodopropynyl butyl carbamate and 0.4 parts by weight of glycol distearate were dissolved by heating to 70° C., filtered, and mixed with the product of step 2) and stirred, cooled to 60° C.; 4) 2 parts by weight of cetrimonium chloride, 0.5 parts by weight of fragrance, 0.5 parts by weight of triethanolamine, 0.5 parts by weight of sodium chloride, 1 part by weight of hydrolyzed keratin, 0.143 parts by weight of sewage extract, 0.143 parts by weight of red ginseng extract, white paper extract 0.143 parts by weight, orchid extract 0.143 parts by weight, Angelica asiatica extract 0.143 parts by weight, pomegranate extract 0.143 parts by weight, rhubarb extract 0.143 parts by weight, copper tripeptide 0.2 parts by weight, graviola extract 0.5 parts by weight, sodium laureth ether sulfate 25 parts by weight And 25 parts by weight of purified water substitute (graviola water) was mixed and stirred with the mixture cooled to 60°C of step 3), cooled to 35°C, and filtered to prepare a hair cosmetic composition.

Claims (4)

다음의 단계를 포함하는 항산화효과, 미백효과, 주름개선효과 및 항염증 효과가 있는 화장료 조성물의 제조방법:
1) 정제수, 카보머 및 디소듐이디티에이를 90℃까지 가온하여 용해한 후 여과하는 단계;
2) 시크릭애씨드, 솔잣나무열매추출물, 글리세린, 디메치콘, 소듐라우릴설페이트 및 코카마이도프로필베타인을 70℃까지 가온하여 용해한 후 상기 1) 단계의 여과물과 혼합교반하는 단계;
3) 코카마이드디이에이, 아이오도프로피닐부틸카바메이트 및 글라이콜디스테아레이트를 70℃까지 가온하여 용해한 후 여과하여 상기 2) 단계의 생성물과 혼합교반하여 60℃까지 냉각하는 단계;
4) 세트리모늄클로라이드, 향료, 트리에탄올아민, 소듐클로라이드, 하이드롤라이즈케라틴, 하수오추출물, 홍삼추출물, 백지추출물, 한련초추출물, 당귀추출물, 석류추출물, 대황추출물, 카퍼트리펩타이드, 그라비올라 에탄올 추출물, 소듐라우레스에테르설페이트 및 그라비올라 열수 추출물을 상기 3) 단계의 생성물과 혼합 교반하여 60℃까지 냉각하고 여과하는 단계.
A method for preparing a cosmetic composition having an antioxidant effect, a whitening effect, an anti-wrinkle effect, and an anti-inflammatory effect, comprising the following steps:
1) dissolving purified water, carbomer and disodium EDTA by heating to 90° C., followed by filtering;
2) cyclonic acid, pine needle fruit extract, glycerin, dimethicone, sodium lauryl sulfate and cocamidopropyl betaine were dissolved by heating to 70° C., followed by mixing and stirring with the filtrate of step 1);
3) Cocamide DEA, iodopropynyl butyl carbamate and glycol distearate were dissolved by heating to 70°C, filtered, mixed with the product of step 2), and cooled to 60°C;
4) Cetrimonium chloride, fragrance, triethanolamine, sodium chloride, hydrolyzed keratin, sewage extract, red ginseng extract, white paper extract, orchid extract, Angelica asiatica extract, pomegranate extract, rhubarb extract, copper tripeptide, graviola ethanol extract, A step of mixing and stirring sodium laureth ether sulfate and graviola hot water extract with the product of step 3), cooling to 60° C., and filtering.
제 1항에 있어서,
정제수 13 내지 17 중량부, 카보너 0.1 내지 0.3 중량부, 디소듐이디티에이 0.05 내지 0.1 중량부, 시크릭애씨드 0.1 내지 0.3 중량부, 솔잣나무열매추출물 0.1 내지 0.3 중량부, 글리세린 1.5 내지 2.0 중량부, 디메치콘 1.5 내지 2.5 중량부, 소듐라우릴설페이트 8 내지 12 중량부, 코카마이도프로필베타인 6 내지 8 중량부, 코카마이드디이에이 6 내지 8 중량부, 아이오도프로피닐부틸카바메이트 0.03 내지 0.05 중량부, 글라이콜디스테아레이트 0.3 내지 0.5 중량부, 세트리모늄클로라이드 1.8 내지 2.2 중량부, 향료 0.3 내지 0.7 중량부, 트리에탄올아민 0.3 내지 0.7 중량부, 소듐클로라이드 0.3 내지 0.7 중량부, 하이드롤라이즈드케라틴 0.8 내지 1.2 중량부, 하수오추출물 0.13 내지 0.15 중량부, 홍삼추출물 0.13 내지 0.15 중량부, 백지추출물 0.13 내지 0.15 중량부, 한련초추출물 0.13 내지 0.15 중량부, 당귀추출물 0.13 내지 0.15 중량부, 석류추출물 0.13 내지 0.15 중량부, 대황추출물 0.13 내지 0.15 중량부, 카퍼트리펩타이드 0.15 내지 0.25 중량부, 그라비올라 에탄올 추출물 0.4 내지 0.6 중량부, 소듐라우에스에테르설페이트 23 내지 27 중량부 및 그라비올라 열수추출물 23 내지 27중량부로 혼합하는 것을 특징으로 하는 방법.
The method of claim 1,
13 to 17 parts by weight of purified water, 0.1 to 0.3 parts by weight of carboner, 0.05 to 0.1 parts by weight of disodium EDTA, 0.1 to 0.3 parts by weight of cyclonic acid, 0.1 to 0.3 parts by weight of pine needle extract, 1.5 to 2.0 parts by weight of glycerin parts, dimethicone 1.5 to 2.5 parts by weight, sodium lauryl sulfate 8 to 12 parts by weight, cocamidopropyl betaine 6 to 8 parts by weight, cocamide DA 6 to 8 parts by weight, iodopropynyl butyl carbamate 0.03 to 0.05 parts by weight, glycol distearate 0.3 to 0.5 parts by weight, cetrimonium chloride 1.8 to 2.2 parts by weight, fragrance 0.3 to 0.7 parts by weight, triethanolamine 0.3 to 0.7 parts by weight, sodium chloride 0.3 to 0.7 parts by weight, 0.8 to 1.2 parts by weight of hydrolyzed keratin, 0.13 to 0.15 parts by weight of sewage extract, 0.13 to 0.15 parts by weight of red ginseng extract, 0.13 to 0.15 parts by weight of white paper extract, 0.13 to 0.15 parts by weight of orchid extract, 0.13 to 0.15 parts by weight of angelicae extract , pomegranate extract 0.13 to 0.15 parts by weight, rhubarb extract 0.13 to 0.15 parts by weight, copper tripeptide 0.15 to 0.25 parts by weight, graviola ethanol extract 0.4 to 0.6 parts by weight, sodium laureth ether sulfate 23 to 27 parts by weight, and graviola hot water Method, characterized in that the extract is mixed with 23 to 27 parts by weight.
제 1항에 있어서,
정제수 15 중량부, 카보너 0.2 중량부, 디소듐이디티에이 0.07 중량부, 시크릭애씨드 0.2 중량부, 솔잣나무열매추출물 0.2 중량부, 글리세린 1.7 중량부, 디메치콘 2 중량부, 소듐라우릴설페이트 10 중량부, 코카마이도프로필베타인 7 중량부, 코카마이드디이에이 7 중량부, 아이오도프로피닐부틸카바메이트 0.04 중량부, 글라이콜디스테아레이트 0.4 중량부, 세트리모늄클로라이드 2 중량부, 향료 0.5 중량부, 트리에탄올아민 0.5 중량부, 소듐클로라이드 0.5 중량부, 하이드롤라이즈드케라틴 1 중량부, 하수오추출물 0.143 중량부, 홍삼추출물 0.143 중량부, 백지추출물 0.143 중량부, 한련초추출물 0.143 중량부, 당귀추출물 0.143 중량부, 석류추출물 0.143 중량부, 대황추출물 0.143 중량부, 카퍼트리펩타이드 0.2 중량부, 그라비올라 에탄올추출물 0.5 중량부, 소듐라우에스에테르설페이트 25 중량부 및 그라비올라 열수추출물 25 중량부로 혼합하는 것을 특징으로 하는 방법.
The method of claim 1,
Purified water 15 parts by weight, Carboner 0.2 parts by weight, Disodium EDITA 0.07 parts by weight, Cyclic acid 0.2 parts by weight, Pine pine fruit extract 0.2 parts by weight, Glycerin 1.7 parts by weight, Dimethicone 2 parts by weight, Sodium lauryl sulfate 10 parts by weight, cocamidopropyl betaine 7 parts by weight, cocamide DA 7 parts by weight, iodopropynyl butyl carbamate 0.04 parts by weight, glycol distearate 0.4 parts by weight, cetrimonium chloride 2 parts by weight , fragrance 0.5 parts by weight, triethanolamine 0.5 parts by weight, sodium chloride 0.5 parts by weight, hydrolyzed keratin 1 part by weight, sewage extract 0.143 parts by weight, red ginseng extract 0.143 parts by weight, white paper extract 0.143 parts by weight, orchid extract 0.143 parts by weight , angelica extract 0.143 parts by weight, pomegranate extract 0.143 parts by weight, rhubarb extract 0.143 parts by weight, copper tripeptide 0.2 parts by weight, graviola ethanol extract 0.5 parts by weight, sodium laureth ether sulfate 25 parts by weight and graviola hot water extract 25 parts by weight A method comprising mixing.
제 1항 내지 3항 중 어느 한 항의 방법에 의해 제조되는 항산화효과, 미백효과, 주름개선효과 및 항염증 효과가 있는 화장료 조성물.A cosmetic composition having an antioxidant effect, a whitening effect, an anti-wrinkle effect, and an anti-inflammatory effect prepared by the method of any one of claims 1 to 3.
KR1020220002831A 2014-06-26 2022-01-07 Cosmetic composition KR102436816B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020220002831A KR102436816B1 (en) 2014-06-26 2022-01-07 Cosmetic composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020140078896A KR20160001102A (en) 2014-06-26 2014-06-26 Hair cosmetic composition comprising the oriental medicin extract of Graviola for improving state of scalp and preventing hair loss
KR1020220002831A KR102436816B1 (en) 2014-06-26 2022-01-07 Cosmetic composition

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020140078896A Division KR20160001102A (en) 2014-06-26 2014-06-26 Hair cosmetic composition comprising the oriental medicin extract of Graviola for improving state of scalp and preventing hair loss

Publications (2)

Publication Number Publication Date
KR20220027092A KR20220027092A (en) 2022-03-07
KR102436816B1 true KR102436816B1 (en) 2022-08-26

Family

ID=55165033

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020140078896A KR20160001102A (en) 2014-06-26 2014-06-26 Hair cosmetic composition comprising the oriental medicin extract of Graviola for improving state of scalp and preventing hair loss
KR1020220002831A KR102436816B1 (en) 2014-06-26 2022-01-07 Cosmetic composition

Family Applications Before (1)

Application Number Title Priority Date Filing Date
KR1020140078896A KR20160001102A (en) 2014-06-26 2014-06-26 Hair cosmetic composition comprising the oriental medicin extract of Graviola for improving state of scalp and preventing hair loss

Country Status (1)

Country Link
KR (2) KR20160001102A (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106423882A (en) * 2016-11-09 2017-02-22 陕西科技大学 Chinese-dates automatic grading equipment
CN108992385A (en) * 2018-08-27 2018-12-14 天津市康婷生物工程有限公司 Hair essence is educated in a kind of hair follicle reparation
KR102143154B1 (en) * 2018-10-16 2020-08-11 홍연희 Manufacturing method of hair loss prevention shampoo containing graviola component extracted in two steps
KR102080412B1 (en) * 2018-11-22 2020-02-21 이정민 Shampoo comprising the extract of graviola for improving condition of scalp and preventing hair loss
KR102229499B1 (en) * 2020-10-21 2021-03-18 세아준뷰티 주식회사 Composition for hair care including copper-peptide complex

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0912433A (en) * 1995-04-28 1997-01-14 Shiseido Co Ltd Composition for head
KR100780180B1 (en) 2006-12-01 2007-11-28 (주)바이오에프디엔씨 Chinese composition preventing loss of hair and promoting growth of hair and method for preparing the same
KR101155502B1 (en) 2008-07-09 2012-06-15 (주) 피엘코스메틱 Oriental hair restorer and the method using the same
KR101212707B1 (en) * 2010-05-26 2012-12-14 재단법인 고창복분자연구소 Cosmetics and toiletries containing extract of Rubus coreanum seeds
KR101103651B1 (en) 2011-02-01 2012-01-11 주식회사 예지미인 Cosmetic composition the oriental medicine mixed extract preventing activity from hair loss
ITVA20110008A1 (en) * 2011-03-25 2012-09-26 Lamberti Spa DETERGENT COMPOSITIONS
KR101243530B1 (en) * 2011-06-29 2013-03-20 김광우 Hair Cosmetic Composition for Growth Promotion of Hairs Containing Extracted Concentrated Solution From Pine Leaves

Also Published As

Publication number Publication date
KR20220027092A (en) 2022-03-07
KR20160001102A (en) 2016-01-06

Similar Documents

Publication Publication Date Title
KR102436816B1 (en) Cosmetic composition
KR101452770B1 (en) Cosmetic composition comprising lactobacillus fermented solution having anti-oxidation, whitening and anti-wrinkle effect
KR101132246B1 (en) The hair growth solution mainly comprised of ginsenoside rg3 and rh2, and the hair treatment composition
KR101494661B1 (en) Composition for hair or scalp treatment comprising fermented black garlic residue and method of preparing the same
KR101111533B1 (en) Whitening cosmetic composition containing the extract of puer tea, black garlic and Moutan Radicis Cortex
KR20200018879A (en) Natural cosmetic formulation with excellent effect for skin-microbiome homeostasis and anti-inflammation
KR20160109953A (en) Cosmetic composition having anti-itching effect containing crude drug extracts
KR20160119967A (en) Cosmetic composition comprising echinacea purpurea extract
KR20130079220A (en) Skin external composition containing extract of soybean root
KR20120067805A (en) Skin whitening and anti-wrinkle composition comprising a fermented plant extract in ulleung island
KR101293007B1 (en) Anti-oxidant and anti-wrinkle composition comprising a fermented juice of jujube fruit
KR20210091430A (en) Cosmetic composition containing natural complex extracts as active ingredient
KR101547758B1 (en) Composition for preventing hair loss and promoting hair growth
KR101243220B1 (en) Skin whitening and anti-wrinkle composition comprising a fermented plant extract in Ulleung island
KR102612017B1 (en) Composition for skin improvement comprising multiple extract
KR101430636B1 (en) Functional cosmetic composition comprising ginsenosides Rh2 and Rg3
KR102152407B1 (en) Cosmetic composition containing phycocyanobilin and its derivative derived from spirulina
KR101679480B1 (en) Cosmetic Compositions Including a Natural Extract for Improvement of Acne
KR101793104B1 (en) Cosmetic composition for whitening skin comprising mixed extract of Cudrania tricuspidata leaf and Morus alba leaf as effective component
KR102057614B1 (en) Preparation method of chunking-dong, guiana, and angelica complex extracts and cosmetic composition for skin whitening, antibacterial and anti-inflammation
KR20170136957A (en) Composition for skin improvement comprising multiple extract
KR20170051077A (en) Composition comprising extract from liriope platyphylla and natural extract
KR101746158B1 (en) Composition for ameliorating atopic dermatitis comprising Gypsophila oldhamiana extract and use thereof
KR20200048305A (en) Pharmaceutical composition for preventing or treating vitiligo comprising extract of Ricinus communis as an active ingredient
KR20160004567A (en) Cosmetic composition comprising an extract of the tissue-cultured raoulia australis shoot and preparation method of the extract

Legal Events

Date Code Title Description
A107 Divisional application of patent
E701 Decision to grant or registration of patent right
GRNT Written decision to grant